BiotechTubeBiotechTube
Home/Pipeline/Forxiga

Forxiga

Type 2 diabetes

ApprovedCommercial

Key Facts

Indication
Type 2 diabetes
Phase
Approved
Status
Commercial
Company
AstraZeneca

About AstraZeneca

AstraZeneca is one of the world's largest pharmaceutical companies, headquartered in Cambridge, UK, with a market capitalization of approximately $285 billion. The company focuses on transformative science including next-generation therapeutics, AI-driven drug discovery, and personalized medicine approaches. AstraZeneca reported strong commercial performance in 2025 with 16 positive Phase 3 study results announced during the year, demonstrating continued pipeline strength across multiple therapeutic areas.

View full company profile

Therapeutic Areas

OncologyCardiovascularRespiratoryMetabolic DiseasesImmunologyRare Diseases

Other Type 2 diabetes Drugs

DrugCompanyPhase
Tirzepatide (Mounjaro)Eli LillyApproved
OrforglipronEli LillyPhase 3
Trulicity (dulaglutide)Eli LillyApproved
siRNA GalXC-GYS2Novo NordiskPhase 1
Amylin/semaglutide combinationNovo NordiskPhase 3
LipaglynZydus LifesciencesApproved
LBS-009Belite BioPreclinical
Jentadueto (Linagliptin/Metformin)YuhanApproved
Nesina (Alogliptin)YuhanApproved
Metformin & CombinationsIpca LaboratoriesCommercial
GSBR-1290Structure TherapeuticsPhase 2
MetforminGranules IndiaApproved/Commercial